National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 1773551

Government Disclaimer on use of this data

History of Changes from the VAERS Wayback Machine

First Appeared on 10/15/2021

VAERS ID: 1773551
VAERS Form:2
Age:66.0
Sex:Female
Location:Unknown
Vaccinated:2021-01-15
Onset:2021-09-28
Submitted:0000-00-00
Entered:2021-10-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 013L20A / 1 - / OT

Administered by: Unknown      Purchased by: ??
Symptoms: Blood cholesterol, Low density lipoprotein, Low density lipoprotein increased

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: REPATHA
Current Illness: Hypercholesteraemia
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Date: 20201022; Test Name: NMR lipoprofile blood test; Result Unstructured Data: 171; Test Date: 20210928; Test Name: NMR lipoprofile blood test; Result Unstructured Data: 202; Test Date: 20201022; Test Name: NMR lipoprofile blood test; Result Unstructured Data: LDL P was 528; Test Date: 20210928; Test Name: NMR lipoprofile blood test; Result Unstructured Data: LDL P was 1219
CDC 'Split Type': USMODERNATX, INC.MOD20213

Write-up: LDL-P was 1219 and her regular cholesterol was 202; This spontaneous case was reported by a consumer and describes the occurrence of LOW DENSITY LIPOPROTEIN INCREASED (LDL-P was 1219 and her regular cholesterol was 202) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 015M20A and 013L20A) for COVID-19 vaccination. Concurrent medical conditions included Hypercholesteraemia since 22-Oct-2020. Concomitant products included EVOLOCUMAB (REPATHA) from September 2020 to an unknown date for Hypercholesterolemia. On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Sep-2021, the patient experienced LOW DENSITY LIPOPROTEIN INCREASED (LDL-P was 1219 and her regular cholesterol was 202). At the time of the report, LOW DENSITY LIPOPROTEIN INCREASED (LDL-P was 1219 and her regular cholesterol was 202) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Oct-2020, Blood cholesterol: 171 (normal) 171. On 22-Oct-2020, Low density lipoprotein: 528 (abnormal) LDL P was 528. On 28-Sep-2021, Blood cholesterol: 202 (High) 202. On 28-Sep-2021, Low density lipoprotein: 1219 (High) LDL P was 1219. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Patient states that she started the medication,repatha in September of 2020 and her numbers were good, she had both doses of the vaccine early this year, had her numbers checked again, and they were way up again.Her NMR lipoprofile blood test on 22 Oct 2020 and her LDL P was 528 and her regular cholesterol was 171. She had another NMR test on 28 Sep 2021 and her LDL P was 1219 and her regular cholesterol was 202. Treatment information was not provided.

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?IDNUMBER=1773551&WAYBACKHISTORY=ON


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166